YACOUB, MONA-RITA
 Distribuzione geografica
Continente #
NA - Nord America 2.948
EU - Europa 2.615
AS - Asia 2.449
SA - Sud America 384
Continente sconosciuto - Info sul continente non disponibili 222
AF - Africa 42
OC - Oceania 16
AN - Antartide 1
Totale 8.677
Nazione #
US - Stati Uniti d'America 2.824
RU - Federazione Russa 1.559
SG - Singapore 980
CN - Cina 787
IT - Italia 435
BR - Brasile 315
HK - Hong Kong 256
VN - Vietnam 193
DE - Germania 142
FR - Francia 127
GB - Regno Unito 94
CA - Canada 66
SE - Svezia 65
IN - India 61
NL - Olanda 56
BD - Bangladesh 39
FI - Finlandia 34
MX - Messico 30
TR - Turchia 23
AR - Argentina 22
PL - Polonia 21
AT - Austria 20
ES - Italia 18
JP - Giappone 17
IQ - Iraq 16
AU - Australia 15
ZA - Sudafrica 15
ID - Indonesia 12
CL - Cile 10
CO - Colombia 10
EC - Ecuador 9
JO - Giordania 7
SA - Arabia Saudita 7
CH - Svizzera 6
MA - Marocco 6
MY - Malesia 6
PK - Pakistan 6
PY - Paraguay 6
DZ - Algeria 5
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
TN - Tunisia 5
UA - Ucraina 5
KE - Kenya 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
IE - Irlanda 3
IL - Israele 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
SV - El Salvador 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SX - ???statistics.table.value.countryCode.SX??? 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
Totale 8.457
Città #
Singapore 552
Moscow 347
Ashburn 327
San Jose 301
Dallas 272
Hong Kong 252
Shanghai 152
Milan 117
Council Bluffs 106
New York 105
Hefei 102
Beijing 94
Lauterbourg 85
Los Angeles 80
Ho Chi Minh City 63
Boardman 44
Atlanta 41
Santa Clara 39
Hanoi 36
Rome 36
Munich 35
São Paulo 34
Guangzhou 30
Orem 29
Shenzhen 29
Nuremberg 28
Cesano Boscone 23
Chennai 23
Denver 21
Helsinki 21
Amsterdam 18
Brooklyn 18
Chicago 18
London 18
Toronto 17
Boston 16
Houston 16
Lawrence 16
Mexico City 16
Montreal 16
Princeton 16
San Francisco 16
Warsaw 15
Phoenix 14
Stockholm 14
Tokyo 14
Biên Hòa 13
Poplar 13
Rio de Janeiro 13
Jiaxing 12
Omaha 12
Buffalo 11
Mumbai 11
Bologna 10
Brisbane 9
Calgary 9
City of London 9
Falkenstein 9
Frankfurt am Main 9
Lappeenranta 9
Manchester 9
Vienna 9
Washington 9
Wuxi 9
Ankara 8
Belo Horizonte 8
Buenos Aires 8
Florence 8
Haiphong 8
Johannesburg 8
Padova 8
St Petersburg 8
Amman 7
Contagem 7
Da Nang 7
Milwaukee 7
Naples 7
Seattle 7
Cleveland 6
Curitiba 6
Querétaro 6
The Dalles 6
Wolfhagen 6
Athens 5
Brasília 5
Changsha 5
Cologne 5
Dhaka 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Jakarta 5
Memphis 5
Ottawa 5
Quanzhou 5
Santiago 5
Sydney 5
Xi'an 5
Baghdad 4
Campo Grande 4
Totale 4.086
Nome #
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 751
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 308
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 221
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media 164
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 158
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 156
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 141
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps 140
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 133
Evolving Clinical Manifestations and Symptom Clusters in Long-COVID Patients: a Comparative Analysis from April 2020 to Present 126
Severe asthma: One disease and multiple definitions 126
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 123
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 122
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 120
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 116
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 116
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 115
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results 115
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 114
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI ) 112
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 111
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study 110
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 110
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation 109
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 109
Characteristics and treatment regimens across ERS SHARP severe asthma registries 109
Assessment of impairment/disability due to occupational asthma through a multidimensional approach 108
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey 101
IgE response to Aed al 13 and Aed al 14 recombinant allergens from Aedes albopictus saliva in humans 98
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach 97
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 96
Asthma caused by cyanoacrylate used in a leisure activity [2] 89
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 88
Caring with compassion during COVID-19 88
CLINICAL AND EPIDEMIOLOGICAL RELEVANCE OF ALLERGY IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN OBSERVATIONAL STUDY 87
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process 86
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis 86
Capitolo 80: Malattie allergiche 83
Do environmental measures improve quality of life in mite-induced allergic rhinitis? 83
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study 83
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 81
Chronic rhinosinusitis with nasal polyps: a pilot study on immunologic dysregulation and the role of sensitisation to aeroallergens 80
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 78
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 77
Occupational asthma and occupational rhinitis in hairdressers 76
EAACI position paper on occupational rhinitis 75
Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease 74
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 71
Drug induced exfoliative dermatitis: State of the art 70
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 70
Eosinophils from Physiology to Disease: A Comprehensive Review 66
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy 65
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 64
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 64
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 63
ITALIAN STUDY ON BUCKWHEAT ALLERGY: PREVALENCE AND CLINICAL FEATURES OF BUCKWHEAT-SENSITIZED PATIENTS IN ITALY 63
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 62
Effects of sublingual immunotherapy on allergic inflammation: An update 61
Systemic allergic reactions induced by labile plant-food allergens: Seeking potential cofactors. A multicenter study 61
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 61
HYPERSENSITIVITY TO RITUXIMAB: A RAPID AND SIMPLIFIED DESENSITIZATION PROTOCOL FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND OTHER AUTOIMMUNE DISORDERS 59
IgG4-related disease and allergen-specific immunotherapy 58
Optimal management of DRESS syndrome in course of infectious endocarditis. 58
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 57
Occupational rhinitis 56
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study 56
World Trade Center disaster: Short- and medium-term health outcome 54
Is itIt's it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? The importance of desensitization procedures in the monoclonal antibodies era 54
Unusual presentation of a serum sickness-like reaction due to sulfonamides 54
Pulmonary rehabilitation as evaluated by clinical trials: An overview 53
Guidelines for the use and interpretation of diagnostic methods in adult food allergy 53
Occupational asthma due to bethabara wood dust 53
Occupational eosinophilic bronchitis 52
Omega-5 gliadin anaphylaxis: An integrated diagnostic approach 51
Immune mechanisms of allergen-specific immunotherapy 51
Resuscitation fluids 51
Usefulness of basophil activation test in gluten sensitivity 51
Effects of sublingual immunotherapy on allergic inflammation 50
Incidence and characteristics of hospital-acquired pneumonia in a pulmonary rehabilitation setting 49
Usefulness of induced sputum in investigating occupational asthma with normal responsiveness to methacholine: A case report 49
Erratum to "Guidelines for the use and interpretation of diagnostic methods in adult food allergy". [Clin Mol Allergy, 13, (2015), 27] DOI: 10.1186/s12948-015-0033-9 48
Usefulness of autologous serum and plasma skin tests in the diagnostic pathway of chronic idiopatic urticaria and/or autoimmune diseases and/or multiple drug allergy 48
Safety of sublingual immunotherapy started during the pollen season 48
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 48
Histamine release test correlates with disease activity in chronic spontaneous urticaria 47
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media. 47
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 46
Multiple drug hypersensivity: Insight into the underlying mechanism and correlation with autoimmune diseases 46
Wheat gastrointestinal hypersensitivity: a case report 45
Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium 45
Usefulness of skin testing in preventing hypersensitivity to iodinated contrast media 44
Is it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? 43
Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order 43
Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis 42
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor 42
Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience 41
Evaluation of basophil activation test in suspected food hypersensitivity 38
Six-minute walk test cut-off value identifying COPD patients with physical disability: A pilot study 33
From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis 7
Chronic urticaria: Not only after COVID-19 vaccination 7
Totale 8.667
Categoria #
all - tutte 39.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 7 7 2 4 4 4 7 1 11 4
2022/2023116 35 24 9 0 2 15 7 8 3 3 4 6
2023/2024523 2 7 18 150 12 83 29 38 5 16 25 138
2024/20251.783 207 39 36 101 209 152 159 179 276 181 123 121
2025/20265.788 371 353 278 637 492 192 546 362 1.342 295 193 727
2026/2027400 242 158 0 0 0 0 0 0 0 0 0 0
Totale 8.677